Orbits Oncology
PrivateLast Round
Accelerator
Feb 27, 2025
Total Funding Raised
$250,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Orbits Oncology is a biotechnology company that develops a cloud-based, AI-powered image analysis and drug screening platform designed to help cancer researchers make decisions in drug development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Precision Medicine, Medical AI, Medical Imaging, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orbits Oncology Comparables
Compare Orbits Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProxyBio | 82% | |
| QuantaCell | 78% | |
| Orakl Oncology | 70% |
Orbits Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 27, 2025 | ||||
| Accelerator | Aug 6, 2024 |
Key People
Founding team and executive leadership
Orbits Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AlphaLab | Accelerator |
| Northpond Ventures | Accelerator |
| McKesson Ventures | Accelerator |
| Innovation Works | Accelerator |
| Merck Digital Sciences Studio | Accelerator |
| New Jersey Innovation Institute | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 96% MoM.
- May 17, 2026
Monthly visitors increased 267% MoM.
Orbits Oncology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Orbits Oncology's valuation, stock price, and market status.
Is Orbits Oncology a public or private company?
Orbits Oncology is a private company.
What is the current stock price of Orbits Oncology?
Orbits Oncology is a private company with no public stock price. No recent secondary market data is available.
How much is Orbits Oncology worth (valuation)?
Valuation information for Orbits Oncology is not publicly available.
Can I buy Orbits Oncology stock?
Orbits Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Orbits Oncology's last funding round?
Orbits Oncology's most recent funding round was Accelerator on February 27, 2025.
Who are the main investors in Orbits Oncology?
Key investors in Orbits Oncology include AlphaLab, Northpond Ventures, McKesson Ventures, Innovation Works, Merck Digital Sciences Studio.
Will Orbits Oncology IPO soon?
No public IPO plans have been announced for Orbits Oncology.
How can I track Orbits Oncology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Orbits Oncology's secondary market activity and sign up for updates.